SummaryTwo independent clinical trials were conducted simultaneously. In one, tramadol and pethidine were compared in 30 patients by patient-controlled analgesia during the first 24 h following abdominal surgery. The mean 24 h consumption of tramadol and pethidine was 642 mg and 606 mg respectively, giving a potency estimate of tramadol relative to pethidine of 0.94 (95% confidence interval0.72-1.17). In the second trial, the effect on respiration of three doses of tramadol(0.5, 1.0, and 2.0 mg.kg-') was compared with that of morphine sulphate (0.143 mg.kg-') by intravenous injection during stable halothane anaesthesia. A t approximately 1.5 times the equipotent dose, as estimated from the first trial, tramadol transiently depressed the rate of respiration but had no effect on end-tidal carbon dioxide tension. Morphine caused apnoea or considerable depression of ventilation. The results suggest that mechanisms other than opioid receptor activity play a significant role in the analgesia produced by tramadol.
Key wordsAnalgesia; postoperative, patient-controlled. Analgesics; morphine, pethidine, tramadol. Measurement techniques; spirometry, gas analysis, visual analogue scores.When a pharmaceutical company approaches an experienced research worker with the story that they have an analgesic drug, with activity at p-opioid receptors but which does not depress respiration, the response is likely to be the scientific equivalent of 'pull the other one'. It is a claim which has often been made but never really substantiated.The work described in this paper was part of a 'crash' programme of studies undertaken in response to such a claim for tramadol, a drug available in Germany since 1977 and marketed in many other countries throughout the world since then, for which a British partner company wished to obtain a Product Licence in the United Kingdom. The ensuing research programme, born initially of some scepticism, attempted to compare this drug in four different but relevant ways with existing standard drugs. These were, (i) a relative potency estimate against pethidine by patient controlled analgesia (PCA), a method of which we had considerable experience [I] and against a drug for which we had previous data [24], (ii) a comparison with morphine (and saline) on the effect of three different doses on respiratory parameters when given intravenously during halothane anaesthesia (again a method with which we had previous experience) [5], (iii) a comparison with codeine as a cough suppressant against ammonia inhalation and (iv) a comparison with morphine (and placebo) on gut motility after minor gynaecological surgery. For various reasons, neither of the two latter trials produced statistically significant results. However, the first two bear most on the point at issue, namely the respiratory depressing potential of tramadol versus other similar analgesics at equipotent doses. Even though, unfortunately, for what seemed good reasons at the time, these two studies were carried out using different comparators, it seems logic...